- Home
- BLX vs BCRX Comparison
BLX vs BCRX Comparison
Compare BLX & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLX
- BCRX
- Stock Information
- Founded
- BLX 1977
- BCRX 1986
- Country
- BLX Panama
- BCRX United States
- Employees
- BLX N/A
- BCRX N/A
- Industry
- BLX Commercial Banks
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLX Finance
- BCRX Health Care
- Exchange
- BLX Nasdaq
- BCRX Nasdaq
- Market Cap
- BLX 1.5B
- BCRX 1.7B
- IPO Year
- BLX N/A
- BCRX 1994
- Fundamental
- Price
- BLX $41.23
- BCRX $9.66
- Analyst Decision
- BLX
- BCRX Buy
- Analyst Count
- BLX 0
- BCRX 8
- Target Price
- BLX N/A
- BCRX $16.75
- AVG Volume (30 Days)
- BLX 102.7K
- BCRX 3.5M
- Earning Date
- BLX 07-22-2025
- BCRX 08-04-2025
- Dividend Yield
- BLX 6.07%
- BCRX N/A
- EPS Growth
- BLX 13.55
- BCRX N/A
- EPS
- BLX 5.60
- BCRX N/A
- Revenue
- BLX $289,499,000.00
- BCRX $503,485,000.00
- Revenue This Year
- BLX $13.23
- BCRX $39.04
- Revenue Next Year
- BLX $7.79
- BCRX $13.26
- P/E Ratio
- BLX $7.36
- BCRX N/A
- Revenue Growth
- BLX 13.37
- BCRX 41.67
- 52 Week Low
- BLX $27.37
- BCRX $6.02
- 52 Week High
- BLX $42.88
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- BLX 51.36
- BCRX 38.90
- Support Level
- BLX $40.66
- BCRX $9.72
- Resistance Level
- BLX $42.29
- BCRX $10.06
- Average True Range (ATR)
- BLX 0.75
- BCRX 0.31
- MACD
- BLX -0.16
- BCRX -0.17
- Stochastic Oscillator
- BLX 26.73
- BCRX 3.09
About BLX Banco Latinoamericano de Comercio Exterior S.A.
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.